Advisory Council on Blood Stem Cell Transplantation; Notice of Meeting, 7131-7132 [2016-02572]

Download as PDF 7131 Federal Register / Vol. 81, No. 27 / Wednesday, February 10, 2016 / Notices used to rapidly reverse the effects of opioid overdose and training of licensed healthcare professionals and emergency responders on their use. Need and Proposed Use of the Information: For this program, performance measures have been drafted to provide data useful to the program and to enable HRSA to provide aggregate program data required by Congress under the Government Performance and Results Act (GPRA) of 1993 (Pub. L. 103–62). These measures cover the principal topic areas of interest to the Federal Office of Rural Health Policy including: (1) The number of counties served by the program; (2) the number and type of devices purchased and distributed and the location of the distribution; (3) the number of training sessions and the number of individuals trained; and (4) the number of individuals who were administered Narcan and the outcome. These measures will speak to the Office’s progress toward meeting the set goals. Likely Respondents: Rural Opioid Overdose Reversal Grant Program award recipients. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this Information Collection Request are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Form name Number of responses per respondent Total responses Average burden per response (in hours) Total burden hours Rural Opioid Overdose Reversal Grant Program ................ 18 1 18 4 72 Total .............................................................................. 18 1 18 4 72 HRSA specifically requests comments on: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Jackie Painter, Director, Division of the Executive Secretariat. [FR Doc. 2016–02571 Filed 2–9–16; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration asabaliauskas on DSK9F6TC42PROD with NOTICES2 Advisory Council on Blood Stem Cell Transplantation; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Council on Blood Stem Cell Transplantation (ACBSCT). Date and Time: March 3, 2016, from 12:00 p.m. to 4:00 p.m. Eastern Standard Time. Place: The meeting will be via audio conference call and Adobe Connect Pro. Status: The meeting will be open to the public. VerDate Sep<11>2014 17:22 Feb 09, 2016 Jkt 238001 Purpose: Pursuant to Public Law 109– 129, 42 U.S.C. 274k (section 379 of the Public Health Service Act, as amended), the ACBSCT advises the Secretary of Health and Human Services and the Administrator, Health Resources and Services Administration (HRSA), on matters related to the activities of the C.W. Bill Young Cell Transplantation Program (Program) and the National Cord Blood Inventory Program. Agenda: The Council will hear a report from the ACBSCT Work Group on Cord Blood. The Council also will hear presentations and discussions on topics including the National Institutes of Health’s Late Effects Initiative and the Center for International Blood and Marrow Transplant Research. Agenda items are subject to changes as priorities indicate. After Council discussions, members of the public will have an opportunity to provide comment. Because of the Council’s full agenda and timeframe in which to cover the agenda topics, public comment may be limited. All public comments will be included in the record of the ACBSCT meeting. Meeting summary notes will be posted on the HRSA’s Program Web site at http:// bloodcell.transplant.hrsa.gov/ABOUT/ Advisory_Council/index.html. The draft meeting agenda will be posted on https://www.blsmeetings.net/ ACBSCT/. Those participating at this meeting should register by visiting https://www.blsmeetings.net/ACBSCT/. The deadline to register for this meeting PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 is Tuesday, March 1, 2016. For all logistical questions and concerns, please contact Anthony Rodell, Seamon Corporation, at (301) 658–3457 or send an email to arodell@ SeamonCorporation.com. The public can join the meeting by: 1. (Audio Portion) Calling the Conference Phone Number (1–800–988– 9777) and providing the Participant Code (6253775); and 2. (Visual Portion) Connecting to the ACBSCT Adobe Connect Pro Meeting using the following URL and entering as GUEST: https:// hrsa.connectsolutions.com/acbsct_ webinar/ (copy and paste the link into your browser if it does not work directly). Participants should call and connect 15 minutes prior to the meeting in order for logistics to be set up. If you have never attended an Adobe Connect meeting, please test your connection using the following URL: https:// hrsa.connectsolutions.com/common/ help/en/support/meeting_test.htm and get a quick overview by following URL: http://www.adobe.com/go/connectpro_ overview. Call (301) 443–0437 or send an email to ptongele@hrsa.gov if you are having trouble connecting to the meeting site. Public Comment: It is preferred that persons interested in providing an oral presentation email a written request, along with a copy of their presentation, to Patricia Stroup, MBA, MPA, Executive Secretary, Advisory Council on Blood Stem Cell Transplantation, E:\FR\FM\10FEN1.SGM 10FEN1 7132 Federal Register / Vol. 81, No. 27 / Wednesday, February 10, 2016 / Notices Healthcare Systems Bureau, Health Resources and Services Administration, at pstroup@hrsa.gov. Requests should contain the name, address, telephone number, email address, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the contact person listed above at least 10 days prior to the meeting. The allocation of time may be adjusted to accommodate the level of expressed interest. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may request it during the public comment period. Public participation and ability to comment may be limited to time as it permits. FOR FURTHER INFORMATION CONTACT: Patricia Stroup, MBA, MPA, Executive Secretary, ACBSCT, Healthcare Systems Bureau, Health Resources and Services Administration, 5600 Fishers Lane, Room 08N182, Rockville, Maryland 20857; telephone at (301) 443–1127. The meeting will be held in Rockville, Maryland. Attendance by the public will be limited to the space available. Interested persons may present data, information, or views, orally or in writing, on issues pending before the Council. Written submissions should be forwarded to the contact person on or before one week prior to the meeting. Oral presentations from the public will be scheduled at the conclusion of the meeting. Individuals interested in making oral presentations are encouraged to notify the contact on or before one week prior to the meeting. Five minutes maximum will be allotted for each presentation. To attend onsite, submit written or brief oral comments, or request special accommodations for persons with disabilities, please register at the SAMHSA Committees’ Web site, http:// nac.samhsa.gov/Registration/ meetingsRegistration.aspx, or communicate with the CSAP Council’s Designated Federal Officer (see contact information below). Substantive program information may be obtained after the meeting by accessing the SAMHSA Committee Web site, http://nac.samhsa.gov/, or by contacting the Designated Federal Officer. Jackie Painter, Director, Division of the Executive Secretariat. Committee Name: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Prevention National Advisory Council. Date/Time/Type: February 24, 2016, from 9:30 a.m. to 4:30 p.m. EST: (OPEN). Place: SAMHSA; 5600 Fishers Lane; Room 5N76 (lobby level); Rockville, MD 20857; Adobe Connect webcast: https://samhsacsap.adobeconnect.com/nac/. Contact: Matthew J. Aumen; Designated Federal Officer; SAMHSA CSAP NAC; 5600 Fishers Lane; Rockville, MD 20857; Telephone: 240–276–2419; Fax: 240–276– 2430; Email: matthew.aumen@ samhsa.hhs.gov. [FR Doc. 2016–02572 Filed 2–9–16; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration asabaliauskas on DSK9F6TC42PROD with NOTICES2 Center for Substance Abuse Prevention; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given for the meeting of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention National Advisory Council (CSAP NAC) on February 24, 2016. The Council was established to advise the Secretary, Department of Health and Human Services (HHS); the Administrator, SAMHSA; and Center Director, CSAP concerning matters relating to the activities carried out by and through the Center and the policies respecting such activities. The meeting will be open to the public and will include discussion of aligning mental and substance use & misuse disorder prevention with health. The meeting will also include updates on CSAP program developments. VerDate Sep<11>2014 17:22 Feb 09, 2016 Jkt 238001 Summer King, Statistician, SAMHSA/CBHSQ/OPAC. [FR Doc. 2016–02573 Filed 2–9–16; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2016–0061] Towing Safety Advisory Committee; Vacancies Coast Guard, DHS. Request for applications. AGENCY: ACTION: The Coast Guard seeks applications for membership on the SUMMARY: PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 Towing Safety Advisory Committee. This Committee advises the Secretary of the Department of Homeland Security on matters relating to shallow draft inland and coastal waterway navigation and towing safety. DATES: Completed applications should reach the Coast Guard on or before March 28, 2016. ADDRESSES: Applicants should send a cover letter expressing interest in an appointment to the Towing Safety Advisory Committee that identifies which membership category the applicant is applying under, along with a resume detailing the applicant’s experience via one of the following methods: • By Email: William.J.Abernathy@ uscg.mil. • By Fax: (202) 372–8379. • By Mail: William J. Abernathy, Alternate Designated Federal Officer, Commandant (CG–OES–2), U.S. Coast Guard, Stop 7509, 2703 Martin Luther King Jr. Ave. SE., Washington, DC 20593–7509. FOR FURTHER INFORMATION CONTACT: William J. Abernathy, Alternate Designated Federal Officer of the Towing Safety Advisory Committee; telephone 202–372–1363; or email at William.J.Abernathy@uscg.mil. SUPPLEMENTARY INFORMATION: The Towing Safety Advisory Committee is a Federal advisory committee which operates under the provisions of Federal Advisory Committee Act, Title 5 United States Code, Appendix. It was established under authority of the Act to establish a Towing Safety Advisory Committee in the Department of Transportation, (Pub. L. 96–380), which was most recently amended by section 621 of the Coast Guard Authorization Act of 2010, (Pub. L. 111–281). The Committee advises the Secretary of Homeland Security on matters relating to shallow-draft inland and coastal waterway navigation and towing safety. This advice also assists the Coast Guard in formulating the position of the United States regarding the towing industry in advance of International Maritime Organization meetings. It is expected that the Committee meets at least twice a year either in the Washington, DC, area or in cities with large towing centers of commerce and populated by high concentrations of towing industry and related businesses. It may also meet for extraordinary purposes. Its subcommittees may also meet to consider specific tasks as required. The Committee and its subcommittees may conduct intercessional telephonic meetings, E:\FR\FM\10FEN1.SGM 10FEN1

Agencies

[Federal Register Volume 81, Number 27 (Wednesday, February 10, 2016)]
[Notices]
[Pages 7131-7132]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-02572]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Council on Blood Stem Cell Transplantation; Notice of 
Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:
    Name: Advisory Council on Blood Stem Cell Transplantation (ACBSCT).
    Date and Time: March 3, 2016, from 12:00 p.m. to 4:00 p.m. Eastern 
Standard Time.
    Place: The meeting will be via audio conference call and Adobe 
Connect Pro.
    Status: The meeting will be open to the public.
    Purpose: Pursuant to Public Law 109-129, 42 U.S.C. 274k (section 
379 of the Public Health Service Act, as amended), the ACBSCT advises 
the Secretary of Health and Human Services and the Administrator, 
Health Resources and Services Administration (HRSA), on matters related 
to the activities of the C.W. Bill Young Cell Transplantation Program 
(Program) and the National Cord Blood Inventory Program.
    Agenda: The Council will hear a report from the ACBSCT Work Group 
on Cord Blood. The Council also will hear presentations and discussions 
on topics including the National Institutes of Health's Late Effects 
Initiative and the Center for International Blood and Marrow Transplant 
Research. Agenda items are subject to changes as priorities indicate.
    After Council discussions, members of the public will have an 
opportunity to provide comment. Because of the Council's full agenda 
and timeframe in which to cover the agenda topics, public comment may 
be limited. All public comments will be included in the record of the 
ACBSCT meeting. Meeting summary notes will be posted on the HRSA's 
Program Web site at http://bloodcell.transplant.hrsa.gov/ABOUT/Advisory_Council/index.html.
    The draft meeting agenda will be posted on https://www.blsmeetings.net/ACBSCT/. Those participating at this meeting should 
register by visiting https://www.blsmeetings.net/ACBSCT/. The deadline 
to register for this meeting is Tuesday, March 1, 2016. For all 
logistical questions and concerns, please contact Anthony Rodell, 
Seamon Corporation, at (301) 658-3457 or send an email to 
arodell@SeamonCorporation.com.
    The public can join the meeting by:
    1. (Audio Portion) Calling the Conference Phone Number (1-800-988-
9777) and providing the Participant Code (6253775); and
    2. (Visual Portion) Connecting to the ACBSCT Adobe Connect Pro 
Meeting using the following URL and entering as GUEST: https://hrsa.connectsolutions.com/acbsct_webinar/ (copy and paste the link into 
your browser if it does not work directly).
    Participants should call and connect 15 minutes prior to the 
meeting in order for logistics to be set up. If you have never attended 
an Adobe Connect meeting, please test your connection using the 
following URL: https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm and get a quick overview by following URL: 
http://www.adobe.com/go/connectpro_overview. Call (301) 443-0437 or 
send an email to ptongele@hrsa.gov if you are having trouble connecting 
to the meeting site.
    Public Comment: It is preferred that persons interested in 
providing an oral presentation email a written request, along with a 
copy of their presentation, to Patricia Stroup, MBA, MPA, Executive 
Secretary, Advisory Council on Blood Stem Cell Transplantation,

[[Page 7132]]

Healthcare Systems Bureau, Health Resources and Services 
Administration, at pstroup@hrsa.gov. Requests should contain the name, 
address, telephone number, email address, and any business or 
professional affiliation of the person desiring to make an oral 
presentation. Groups having similar interests are requested to combine 
their comments and present them through a single representative. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the contact person listed above at least 10 days prior to the 
meeting.
    The allocation of time may be adjusted to accommodate the level of 
expressed interest. Persons who do not file an advance request for a 
presentation, but desire to make an oral statement, may request it 
during the public comment period. Public participation and ability to 
comment may be limited to time as it permits.

FOR FURTHER INFORMATION CONTACT: Patricia Stroup, MBA, MPA, Executive 
Secretary, ACBSCT, Healthcare Systems Bureau, Health Resources and 
Services Administration, 5600 Fishers Lane, Room 08N182, Rockville, 
Maryland 20857; telephone at (301) 443-1127.

Jackie Painter,
Director, Division of the Executive Secretariat.
[FR Doc. 2016-02572 Filed 2-9-16; 8:45 am]
 BILLING CODE 4165-15-P